Format

Send to

Choose Destination
See comment in PubMed Commons below
Genome Med. 2013 Oct 18;5(10):93. doi: 10.1186/gm499. eCollection 2013.

The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system.

Author information

1
The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA.
2
The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA ; Current Address: American Red Cross, 700 Spring Garden Street, Philadelphia, PA 19123, USA.
3
The Coriell Institute for Medical Research, 403 Haddon Avenue, Camden, NJ 08103, USA ; Current Address: Annals of Internal Medicine, 190 N. Independence Mall West, Philadelphia, PA 19106, USA.

Abstract

Implementation of pharmacogenomics (PGx) in clinical care can lead to improved drug efficacy and reduced adverse drug reactions. However, there has been a lag in adoption of PGx tests in clinical practice. This is due in part to a paucity of rigorous systems for translating published clinical and scientific data into standardized diagnostic tests with clear therapeutic recommendations. Here we describe the Pharmacogenomics Appraisal, Evidence Scoring and Interpretation System (PhAESIS), developed as part of the Coriell Personalized Medicine Collaborative research study, and its application to seven commonly prescribed drugs.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Support Center